Cargando…
LCZ696 Ameliorates Oxidative Stress and Pressure Overload-Induced Pathological Cardiac Remodeling by Regulating the Sirt3/MnSOD Pathway
AIMS: We aimed to investigate whether LCZ696 protects against pathological cardiac hypertrophy by regulating the Sirt3/MnSOD pathway. METHODS: In vivo, we established a transverse aortic constriction animal model to establish pressure overload-induced heart failure. Subsequently, the mice were given...
Autores principales: | Peng, Shi, Lu, Xiao-feng, Qi, Yi-ding, Li, Jing, Xu, Juan, Yuan, Tian-you, Wu, Xiao-yu, Ding, Yu, Li, Wen-hua, Zhou, Gen-qing, Wei, Yong, Li, Jun, Chen, Song-wen, Liu, Shao-wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519988/ https://www.ncbi.nlm.nih.gov/pubmed/33014281 http://dx.doi.org/10.1155/2020/9815039 |
Ejemplares similares
-
LCZ696 ameliorates lipopolysaccharide-induced endothelial injury
por: Gao, Aihong, et al.
Publicado: (2021) -
LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats
por: Miyoshi, Toru, et al.
Publicado: (2022) -
Safety of the neprilysin/renin-angiotensin system inhibitor LCZ696
por: Li, Bo, et al.
Publicado: (2017) -
Tetramerization Reinforces the Dimer Interface of MnSOD
por: Sheng, Yuewei, et al.
Publicado: (2013) -
A Meta-Analysis on the Effect and Safety of LCZ696 in the Treatment of Hypertension
por: Zheng, Li, et al.
Publicado: (2021)